In support of this hypothesis, EBV-positive infectious mononucleosis patients display a significant increase in IL-17A-producing CD4+ T cells, an increase that persists at least 1 month following the resolution of clinical symptoms (44). This evidence concerns the gene IL17A and infectious mononucleosis.